ReviewFrontiers in molecular biosciences2026
Structural and ensemble-based mechanistic insights into cytoplasmic dynein-1.
Review in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cytoplasmic dynein-1 is a multi-subunit motor that transports diverse cargoes toward microtubule minus-ends, playing crucial roles in intracellular organisation and cell division. Over the past decade, X-ray crystallography and cryo-EM approaches have captured numerous high-resolution structures of dynein's components and complexes ranging from motor domain structures and microtubule binding domain (MTBD)-tubulin complexes, to the autoinhibited and open dynein dimers, activated dynein-dynactin-adaptor assemblies, and LIS1-bound intermediates. These findings have highlighted dynein's architecture and partial conformational cycle, including key intermediates in its activation and assembly with dynactin and cargo adaptors. However, a unified molecular model that links ATP hydrolysis at multiple AAA+ sites to the coordinated motions of dynein's components and their regulation by dynactin, cargo adaptors, and LIS1 remains elusive. Existing mechanistic models rely on discrete structural states and simplified kinetic schemes, which fail to capture conformational heterogeneity and regulator-specific effects. In this mini review, we summarise the current structural and mechanistic knowledge of cytoplasmic dynein-1, highlighting the motor's stepping mechanism and cofactor functions. We then discuss computational approaches including molecular dynamics simulations, enhanced sampling techniques, and integrative modelling that can merge these specific states into quantitative conformational landscapes. This ensemble view will be helpful for understanding dynein's mechanism from a dynamical perspective.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.